News

Apr. 15, 2025 — Certain common genetic changes might make some people with focal epilepsy less responsive to seizure medications, finds a new global ... Could an Arthritis Drug Unlock Lasting ...
Short-term outcomes for epileptic patients improved following the new International League Against Epilepsy definition and diagnosis criteria. HealthDay News — The new International League ...
Get Instant Summarized Text (Gist) Common genetic variants in the genes CNIH3 and WDR26 are linked to drug resistance in focal epilepsy, affecting the efficacy of antiseizure medications. This ...
Get Instant Summarized Text (Gist) The updated International League Against Epilepsy definition increases the frequency of epilepsy diagnosis and treatment. In a study of 235 patients with a first ...
Researchers found that 62.1% of patients were diagnosed with epilepsy, following the new International League Against Epilepsy criteria. HealthDay News — The new International League Against ...
MADISON, Wis. -– Federal cuts pose a threat to epilepsy programs and research including those from the Epilepsy Foundation of Wisconsin. The purpose of the foundation is to give people with ...
BOWIE, Md., April 16, 2025 (GLOBE NEWSWIRE) -- The Epilepsy Foundation of America is proud to announce the release of the Epilepsy & Seizure Safe Classrooms Toolkit, a comprehensive educational ...
Certain common genetic changes might make some people with focal epilepsy less responsive to seizure medications, finds a new global study led by researchers at UCL and UTHealth Houston.
Certain common genetic changes might make some people with focal epilepsy less responsive to seizure medications, finds a new global study. Certain common genetic changes might make some people ...
Sebastian Johnston, 21, wants to see more understanding for young people living with epilepsy. He was diagnosed with epilepsy about a year ago, when he had a seizure out of the blue. Leeanne ...
The expanded indication was supported by data from a phase 1/2 pharmacokinetics (PK) study (ClinicalTrials.gov Identifier: NCT05076838) that evaluated diazepam nasal spray in pediatric epilepsy ...
Researchers from the Epilepsy Neurogenetics Initiative (ENGIN) at Children's Hospital of Philadelphia (CHOP) have completed a comprehensive natural history study of SCN8A-related disorders ...